GeoVax Labs Warrants
GOVXW
GOVXW was delisted on the 26th of September, 2025.
3 hedge funds and large institutions have $118K invested in GeoVax Labs Warrants in 2021 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.
25% less funds holding
Funds holding: 4 → 3 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
91% less capital invested
Capital invested by funds: $1.28M → $118K (-$1.16M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$12.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$887K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$283K |
| 3 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$25.8K |
GOVXW Hedge Fund Activity: Q1 2021 in Review
3 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in GeoVax Labs Warrants (GOVXW) for Q1 2021, worth a combined $118K — down 91% from $1.28M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of GOVXW and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest buyer was UBS Group, opening a new position worth an estimated $12.5K. The largest seller was Armistice Capital, exiting entirely with an estimated $887K sold.
- 3 institutional investors held GeoVax Labs Warrants (GOVXW) as of Q1 2021, down from 4 in Q4 2020.
- Funds reported $118K of GeoVax Labs Warrants stock for Q1 2021, down 91% quarter-over-quarter.
- 1 fund opened new GeoVax Labs Warrants positions in Q1 2021 and 2 closed out, a net change of -1 holder.
- The largest GeoVax Labs Warrants buyer in Q1 2021 was UBS Group, an estimated $12.5K added.
- The largest GeoVax Labs Warrants seller in Q1 2021 was Armistice Capital, an estimated $887K sold.
Based on aggregated 13F filings for Q1 2021.